©2024 Stanford Medicine
Emollient Therapy for Premature Infants in Zimbabwe
Not Recruiting
Trial ID: NCT05461404
Purpose
The purpose of this study is to assess the efficacy of topical emollient treatments in improving neonatal growth and mortality rates.
Official Title
Emollient Therapy for Improved Survival and Growth of Very Low Birth Weight Infants in Zimbabwe
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
* infants \<72 hours of age
* weigh 700-1500 at birth
* hospitalized at SMCH
Exclusion Criteria:
* infants who are moribund and highly likely not to survive despite any intervention
* significant breaches in their skin barrier
* conditions indicating failure to gain weight
* critically ill (definition below):
1. Oxygen saturation \<88% on oxygen therapy AND ≥2 of the following conditions:
2. respiratory rate \<20 or \>100 breaths per minute
3. apnea requiring bag-mask ventilation
4. heart rate \<100 or \>200 beats per minute
* congenital syphilis
* hydrops fetalis
* a life-threatening congenital anomaly or major surgical condition requiring intervention
* generalized skin disease or a structural defect involving \>5% body surface area likely to produce a defect in epidermal barrier function
Intervention(s):
other: Topical Emollient Therapy
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gary Darmstadt, MD, MS
650-724-6014